Determination of the Permeation and Penetration of Flurbiprofen into Cadaveric Human Pharynx Tissue

• Published in: Clinical pharmacology: advances and applications Vol. 12; pp. 13 - 20
• Main Authors: Turner, Rob, Wevrett, Sean Robert, Edmunds, Suzanne, Brown, Marc B, Atkinson, Robert, Adegoke, Oluwajoba, Kulasekaran, Anuradha, Shea, Tim
• Format: Journal Article
• Language: English
• Published: New Zealand Dove Medical Press Limited 01-01-2020; Taylor & Francis Ltd; Dove; Dove Medical Press
• Subjects: Analysis; Chromatography; Cotton; Drug dosages; Epithelium; Experiments; Fluids; Flurbiprofen; franz diffusion cell; High performance liquid chromatography; high pressure liquid; Inflammation; Nonsteroidal anti-inflammatory agents; Original Research; Pain; pharynx; Physiological aspects; Setting (Literature); Sore throat; Throat surgery; United Kingdom; United Kingdom > UK; high-pressure liquid; flurbiprofen; pharynx; Franz diffusion cell; chromatography
• ISSN: 1179-1438; 1179-1438
• DOI: 10.2147/CPAA.S234227

Flurbiprofen 8.75 mg spray and lozenge have a rapid onset of action for sore throat relief, suggesting local action, although tissue penetration and the mechanism of local relief have not been determined. This investigation aimed to quantify the permeation and penetration of flurbiprofen, applied as local pharmaceutical forms, into full-thickness cadaveric human mucosal pharynx tissue, representing the clinical scenario as far as possible.
A validated high-performance liquid chromatography method quantified the permeation and penetration of flurbiprofen (spray and lozenge formulations) into human cadaveric pharynx tissue using a micro Franz cell model mimicking physiological and anatomical conditions. Full-thickness mucosal pharynx tissue, consisting of oral epithelium, basement membrane, and lamina propria, was utilized to imitate the in vivo setting. Flurbiprofen was analyzed on the surface of the pharynx tissue, within the pharynx tissue and in receiver fluid, over 60 mins.
Flurbiprofen was detected in receiver fluid from 10 mins following spray application and was quantifiable from 20 mins. Flurbiprofen from lozenge was detected from 10 mins and was above the limit of quantitation in receiver fluid from 40 mins. Flurbiprofen recovered from the surface of the pharynx tissue was 24.45% and 8.48% of applied dose for spray and lozenge, respectively. Flurbiprofen recovered within pharynx tissue was 46.50% and 54.65% of applied dose for spray and lozenge, respectively. For flurbiprofen lozenge, recovery within pharynx tissue was 6-fold higher relative to recovery from the pharynx tissue surface.
Flurbiprofen from spray and lozenge formulations penetrated human cadaveric pharynx tissue, indicating that flurbiprofen can reach all layers of the pharynx mucosal tissue, including the underlying lamina propria, which contains blood vessels and nerve fibers that contribute to pain during sore throat. This suggests that flurbiprofen may have a local mechanism of action for sore throat, although this has yet to be determined.